Table 1.

Sample origin, coverage, and specificity

Samples*	All reads	On target	Specificity	Coverage	Purpose
BC1	23,121,252	21,691,580	0.94	443	Discovery
BC2	24,444,387	22,385,092	0.92	464	Discovery
BC5	19,576,378	18,062,589	0.93	371	Discovery
BCBL1	25,674,276	24,135,660	0.94	497	Discovery
BCLM	19,605,945	18,085,981	0.92	370	Discovery
BCP1	16,616,184	13,967,038	0.84	289	Discovery
JSC1	10,290,737	9,285,549	0.90	173	Discovery
VG1	23,332,697	21,419,478	0.92	439	Discovery
Mean ± SD				380 ± 107
TY1	4,791,393	4,535,046	0.95	58	Validation
AP2	4,096,685	3,330,357	0.81	42	Validation
AP3	3,017,097	2,445,597	0.81	33	Validation
AP5	3,703,516	3,385,599	0.91	45	Validation
BC3	2,349,785	1,800,776	0.77	24	Validation
Patient 1	4,535,193	4,377,692	0.97	59	Validation
HHB2	3,057,278	2,698,232	0.88	31	Validation
ISI1	1,830,663	1,496,222	0.82	20	Validation
Mean ± SD				39 ± 15

^*Sample origin is described in Roy et al. (5).